BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22058034)

  • 21. Induced pluripotent stem cells and their use in cardiac and neural regenerative medicine.
    Skalova S; Svadlakova T; Shaikh Qureshi WM; Dev K; Mokry J
    Int J Mol Sci; 2015 Feb; 16(2):4043-67. PubMed ID: 25689424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental approaches for the generation of induced pluripotent stem cells.
    Sommer CA; Mostoslavsky G
    Stem Cell Res Ther; 2010 Aug; 1(3):26. PubMed ID: 20699015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications.
    Liu G; David BT; Trawczynski M; Fessler RG
    Stem Cell Rev Rep; 2020 Feb; 16(1):3-32. PubMed ID: 31760627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The genomic stability of induced pluripotent stem cells.
    Chen Z; Zhao T; Xu Y
    Protein Cell; 2012 Apr; 3(4):271-7. PubMed ID: 22528751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.
    Shtrichman R; Germanguz I; Itskovitz-Eldor J
    Curr Mol Med; 2013 Jun; 13(5):792-805. PubMed ID: 23642060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomaterial aided differentiation and maturation of induced pluripotent stem cells.
    Velmurugan BK; Bharathi Priya L; Poornima P; Lee LJ; Baskaran R
    J Cell Physiol; 2019 Jun; 234(6):8443-8454. PubMed ID: 30565686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.
    Brix J; Zhou Y; Luo Y
    J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Generation of Induced Pluripotent Stem Cells with Substitutes for Yamanaka's Four Transcription Factors.
    Xiao X; Li N; Zhang D; Yang B; Guo H; Li Y
    Cell Reprogram; 2016 Oct; 18(5):281-297. PubMed ID: 27696909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.
    Borgohain MP; Haridhasapavalan KK; Dey C; Adhikari P; Thummer RP
    Stem Cell Rev Rep; 2019 Apr; 15(2):286-313. PubMed ID: 30417242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology.
    Easley CA
    Methods Mol Biol; 2019; 1965():19-34. PubMed ID: 31069666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of induced pluripotent stem cells in domestic animals: a narrative review.
    Scarfone RA; Pena SM; Russell KA; Betts DH; Koch TG
    BMC Vet Res; 2020 Dec; 16(1):477. PubMed ID: 33292200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells.
    Paull D; Sevilla A; Zhou H; Hahn AK; Kim H; Napolitano C; Tsankov A; Shang L; Krumholz K; Jagadeesan P; Woodard CM; Sun B; Vilboux T; Zimmer M; Forero E; Moroziewicz DN; Martinez H; Malicdan MC; Weiss KA; Vensand LB; Dusenberry CR; Polus H; Sy KT; Kahler DJ; Gahl WA; Solomon SL; Chang S; Meissner A; Eggan K; Noggle SA
    Nat Methods; 2015 Sep; 12(9):885-92. PubMed ID: 26237226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Returning to the stem state: epigenetics of recapitulating pre-differentiation chromatin structure.
    Shafa M; Krawetz R; Rancourt DE
    Bioessays; 2010 Sep; 32(9):791-9. PubMed ID: 20652894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induced pluripotent stem cells in regenerative medicine and disease modeling.
    Walmsley GG; Hyun J; McArdle A; Senarath-Yapa K; Hu MS; Chung MT; Wong VW; Longaker MT; Wan DC
    Curr Stem Cell Res Ther; 2014 Mar; 9(2):73-81. PubMed ID: 24359141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
    Qi SD; Smith PD; Choong PF
    ANZ J Surg; 2014 Jun; 84(6):E1-11. PubMed ID: 23035845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ROCK inhibition facilitates the generation of human-induced pluripotent stem cells in a defined, feeder-, and serum-free system.
    Lai WH; Ho JC; Lee YK; Ng KM; Au KW; Chan YC; Lau CP; Tse HF; Siu CW
    Cell Reprogram; 2010 Dec; 12(6):641-53. PubMed ID: 20858051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human induced pluripotent stem cells--from mechanisms to clinical applications.
    Drews K; Jozefczuk J; Prigione A; Adjaye J
    J Mol Med (Berl); 2012 Jul; 90(7):735-45. PubMed ID: 22643868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concise review: Deciphering the mechanism behind induced pluripotent stem cell generation.
    Lin SL
    Stem Cells; 2011 Nov; 29(11):1645-9. PubMed ID: 21948625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and characterization of integration-free induced pluripotent stem cells from patients with autoimmune disease.
    Son MY; Lee MO; Jeon H; Seol B; Kim JH; Chang JS; Cho YS
    Exp Mol Med; 2016 May; 48(5):e232. PubMed ID: 27174201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.